Increased PECAM-1 in the serum of patients with SLE may also be modulated by a greater proportion of metabolic syndrome risk factors including increased age, Body Mass Index (BMI) and waist circumference which may increase PECAM-1 levels. The gene discussed is PECAM1; the disease is systemic lupus erythematosus.